Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

Endo A.

J Antibiot (Tokyo). 1979 Aug;32(8):852-4. No abstract available.

2.

Production of the secondary metabolites gamma-aminobutyric acid and monacolin K by Monascus.

Su YC, Wang JJ, Lin TT, Pan TM.

J Ind Microbiol Biotechnol. 2003 Jan;30(1):41-6.

PMID:
12545385
3.

Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis.

Endo A, Hasumi K, Nakamura T, Kunishima M, Masuda M.

J Antibiot (Tokyo). 1985 Mar;38(3):321-7.

4.

Monacolin M, a new inhibitor of cholesterol biosynthesis.

Endo A, Komagata D, Shimada H.

J Antibiot (Tokyo). 1986 Dec;39(12):1670-3.

5.
6.

Metabolites of Monascus ruber in silages.

Schneweis I, Meyer K, Hörmansdorfer S, Bauer J.

J Anim Physiol Anim Nutr (Berl). 2001 Feb;85(1-2):38-44.

PMID:
11686771
7.

Biosynthesis of monacolins: conversion of monacolin J to monacolin K (mevinolin).

Kimura K, Komagata D, Murakawa S, Endo A.

J Antibiot (Tokyo). 1990 Dec;43(12):1621-2. No abstract available.

9.

Monascus rice products.

Wang TH, Lin TF.

Adv Food Nutr Res. 2007;53:123-59. Review.

PMID:
17900498
10.

Biosynthesis of ML-236B (compactin) and monacolin K.

Endo A, Negishi Y, Iwashita T, Mizukawa K, Hirama M.

J Antibiot (Tokyo). 1985 Mar;38(3):444-8. No abstract available.

11.
12.

Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and antioxidative effect.

Lee CL, Wang JJ, Pan TM.

Appl Microbiol Biotechnol. 2008 Jul;79(5):829-41. doi: 10.1007/s00253-008-1480-8.

PMID:
18438657
13.

Cloning and characterization of monacolin K biosynthetic gene cluster from Monascus pilosus.

Chen YP, Tseng CP, Liaw LL, Wang CL, Chen IC, Wu WJ, Wu MD, Yuan GF.

J Agric Food Chem. 2008 Jul 23;56(14):5639-46. doi: 10.1021/jf800595k.

PMID:
18578535
14.

Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus ruber.

Endo A, Hasumi K, Negishi S.

J Antibiot (Tokyo). 1985 Mar;38(3):420-2. No abstract available.

15.

Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreus.

Albers-Schönberg G, Joshua H, Lopez MB, Hensens OD, Springer JP, Chen J, Ostrove S, Hoffman CH, Alberts AW, Patchett AA.

J Antibiot (Tokyo). 1981 May;34(5):507-12.

16.

Origin of monacolin L from Aspergillus terreus cultures.

Treiber LR, Reamer RA, Rooney CS, Ramjit HG.

J Antibiot (Tokyo). 1989 Jan;42(1):30-6.

17.

Biosynthesis of monacolins: conversion of monacolin L to monacolin J by a monooxygenase of Monascus ruber.

Komagata D, Shimada H, Murakawa S, Endo A.

J Antibiot (Tokyo). 1989 Mar;42(3):407-12.

18.

Toxicity of (4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol)), probucol, in mice, rats, dogs and monkeys: demonstration of a species-specific phenomenon.

Molello JA, Gerbig CG, Robinson VB.

Toxicol Appl Pharmacol. 1973 Apr;24(4):590-3. No abstract available.

PMID:
4197359
19.
20.

Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B).

Serizawa N, Nakagawa K, Hamano K, Tsujita Y, Terahara A, Kuwano H.

J Antibiot (Tokyo). 1983 May;36(5):604-7. No abstract available.

Items per page

Supplemental Content

Support Center